Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect of CytoDyn Inc. from 31 May 2016 to 31 Aug 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
CytoDyn Inc. quarterly and annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect in USD history and change rate from 31 May 2016 to 31 Aug 2025.
  • CytoDyn Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for the quarter ending 31 Aug 2025 was $2,571,000, a 117% decline year-over-year.
  • CytoDyn Inc. annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2024 was $2,089,000, a 173% increase from 2023.
  • CytoDyn Inc. annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2023 was $766,000, a 84% decline from 2022.
  • CytoDyn Inc. annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2022 was $4,817,000.
Source SEC data
View on sec.gov
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Quarterly (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, YoY Quarterly Change (%)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Annual (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, YoY Annual Change (%)

CytoDyn Inc. Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $2,571,000 -$17,678,000 -117% 01 Jun 2025 31 Aug 2025 10-Q 10 Oct 2025 2026 Q1
Q3 2024 $15,107,000 +$15,583,000 01 Jun 2024 31 Aug 2024 10-Q 10 Oct 2025 2026 Q1
Q3 2023 $476,000 -$921,000 -207% 01 Jun 2023 31 Aug 2023 10-Q 15 Oct 2024 2025 Q1
Q3 2022 $445,000 +$27,846,000 01 Jun 2022 31 Aug 2022 10-Q 23 Oct 2023 2024 Q1
Q3 2021 $27,401,000 -$31,322,000 -799% 01 Jun 2021 31 Aug 2021 10-Q/A 13 Oct 2022 2023 Q1
Q3 2020 $3,921,000 +$5,592,000 01 Jun 2020 31 Aug 2020 10-Q 12 Oct 2021 2021 Q1
Q3 2019 $1,671,000 -$5,188,968 -147% 01 Jun 2019 31 Aug 2019 10-Q 09 Oct 2020 2020 Q1
Q3 2018 $3,517,968 +$4,347,304 01 Jun 2018 31 Aug 2018 10-Q 08 Oct 2019 2020 Q1
Q3 2017 $829,336 01 Jun 2017 31 Aug 2017 10-Q 09 Oct 2018 2019 Q1

CytoDyn Inc. Annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $2,089,000 +$1,323,000 +173% 01 Jun 2024 31 May 2025 10-K 25 Jul 2025 2025 FY
2023 $766,000 -$4,051,000 -84% 01 Jun 2023 31 May 2024 10-K 25 Jul 2025 2025 FY
2022 $4,817,000 +$34,529,000 01 Jun 2022 31 May 2023 10-K 15 Aug 2024 2024 FY
2021 $29,712,000 -$49,363,000 -251% 01 Jun 2021 31 May 2022 10-K 14 Sep 2023 2023 FY
2020 $19,651,000 +$8,826,000 +82% 01 Jun 2020 31 May 2021 10-K 15 Aug 2022 2022 FY
2019 $10,825,000 +$8,589,000 +384% 01 Jun 2019 31 May 2020 10-K 15 Aug 2022 2022 FY
2018 $2,236,000 +$2,780,138 01 Jun 2018 31 May 2019 10-K 30 Jul 2021 2021 FY
2017 $544,138 +$7,322,055 +93% 01 Jun 2017 31 May 2018 10-K 14 Aug 2020 2020 FY
2016 $7,866,193 -$16,457,909 -192% 01 Jun 2016 31 May 2017 10-K 14 Aug 2019 2019 FY
2015 $8,591,716 01 Jun 2015 31 May 2016 10-K 27 Jul 2018 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.